Bio Path | BPTH - Des Atouts





Des Atouts Changement Date
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Baxter International USD 19.85B 209M 2026-03
Bio Path USD 677K 13K 2026-03
Cipla INR 424.96B 23.32B 2026-03
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 145.86M 10.71M 2026-03
CSL USD 37.9B 1.5B 2025-12
Grifols EUR 23.15B 142.7M 2025-12
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12